Navigation Links
Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
Date:4/10/2008

SAN FRANCISCO, April 10 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that positive preclinical and clinical results for its pipeline programs will be presented at numerous medical and scientific meetings over the coming months. These presentations will highlight Nektar's novel therapeutic candidates in the areas of oncology, anti-infectives and central nervous system (CNS), which leverage Nektar's innovative small molecule PEGylation and liquid aerosol platforms.

The data presentations are as follows:

-- April 12-16, 2008: Presentation of Positive Preclinical Data for NKTR-102 (PEG-irinotecan) at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, California:

Poster #766: "Enhanced anti-tumor activity of NKTR-102, a novel

PEGylated-irinotecan, when administered in combination with

bevacizumab in a mouse model of human colorectal tumors"

Poster #5741: "NKTR-102, a novel PEGylated-irinotecan, has an

enhanced pharmacokinetic profile with reduced gastrointestinal and

hematopoietic toxicity compared to irinotecan with repeat dosing"

Poster #5742: "NKTR-102, a novel PEGylated-irinotecan, has a

superior acute safety, tolerability, and pharmacokinetic profile

compared to irinotecan"

-- May 8-10, 2008: Presentation of Phase 1 Clinical Trial Multi-Dose Safety Data for NKTR-118 (oral PEG-naloxol) in Opioid Bowel Dysfunction at the American Pain Society (APS) Meeting in Tampa, Florida:

Poster #210: "Results from a phase I, double-blind, randomized,

placebo-controlled, multiple-dose study evaluating the safety,

t
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
4. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
7. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
8. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
9. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov. 25 ChemoCentryx, Inc., anno...he Company,s PROTECT-1 (the Prospective Randomized... of Traficet-EN(TM) (CCX282-B) in patients with mo...ical efficacy with a favorable safety and tolerabi...clinical efficacy in the reduction of disease seve...
(Date:11/24/2009)...PRNewswire/ -- ,, WHAT: Rom Houbens, a Belgia...llowing an auto accident, was actually fully consc...t of a Good Morning America segment. The DynaVox ...ow people with Locked-in Syndrome and other condit...orning America -- Tuesday, November 24 available...
(Date:11/24/2009)... 24 Quest Diagnostics In...vider of diagnostic testing, information and servi...e 21st Annual Piper Jaffray Healthcare Conference ...or Wednesday, December 2, 2009 at 9:30 a.m. Easter...ill reaffirm its 2009 guidance for revenue growth ...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Perspectives Ltd and Chicagoland Chamber of Commerce Partner to Promote Drug Free Workplaces EAP Provider Offers Workshops to Help Businesses Underst 59794 1Perspectives Ltd and Chicagoland Chamber of Commerce Partner to Promote Drug Free Workplaces EAP Provider Offers Workshops to Help Businesses Underst 59794 2Perspectives Ltd and Chicagoland Chamber of Commerce Partner to Promote Drug Free Workplaces EAP Provider Offers Workshops to Help Businesses Underst 59794 3Johnson Matthey Expands San Diego Facility 59790 1Johnson Matthey Expands San Diego Facility 59790 2Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 1Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 2Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 3Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 4
...Med today reported one year,survival results from ...imexon(R) (imexon for injection) in combination wi... III or stage IV metastatic malignant,melanoma. Re... Phase I and,Phase II shows a 11.7 month overall m...onth overall mean survival in the subset of patien...
...traZeneca (NYSE:,AZN) today announced that the com...rug Applications (sNDAs) to the U.S. Food and Drug...M) (quetiapine fumarate),Extended-Release Tablets ...es associated with bipolar disorder and the treatm... disorder., The bipolar mania submission is based...
Other Medicine Technology:AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 2AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 3AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 4AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 2AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 3AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 4AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 5AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 6AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 7
(Date:11/27/2009)... Considered a highly ris...rs ago, solid organ transplantation is now a life-...inary men and women who gathered at the Winspear O...ther from medical centers around the world to cele...splant Institute (BRTI), one of the pioneers of so...
(Date:11/27/2009)...srael, Nov. 27 Shamir Op... a leading provider of innovative products and tec...oday that its board of directors had declared a di...10 million (approximately NIS 37.62 million based ...change), or approximately US$ 0.609 (approximately...
(Date:11/27/2009)...SEATTLE, Nov. 27 Allrecipes.com ...Thanksgiving traffic numbers, with more than 2.8 m...ding a clear picture of what was served on the big...iving meal in 2009 weighed in at 2,225 calories pe...east. According to the Allrecipes site, Sweet Pot...
(Date:11/27/2009)...ree new interactive anatomy education apps from Mo...d health sciences learning opportunities for iPhon..., NC (Vocus) November 27, 2009 -- Modality, Inc. ...vision of Wolters Kluwer Health, today announced t...s on the App Store. Clemente’s Anatomy, Rohe...
(Date:11/26/2009)...ug tetrathiomolybdate (TM) has been shown in studi...ase, a disease caused by an overload of copper, an...Very little, however, is known about how the drug ...by Northwestern University researchers now has pro...ructure of TM bound to copper-loaded metallochaper...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...rmer First Lady of the United States, late Jacquel...t daughter Caroline Kennedys weight , that her dau... as much as her weight gain. In the book Am...dessert in a Paris restaurant. You're not ...
...new study has revealed that Acute mountain sicknes...ng to heights over 3,000m, may lead to life-threa... edema. The interest of the general public ... of the Internet. In spite of these apparent chang...
...ian countries must remain vigilant against deadly ...a top UN health agency official said on Tuesday. ...ld have done a lot to fight the virus. But in spit... concerned. We must avoid human transmission," he ...
...stricting use of drugs for macular degeneration to...s unacceptable concludes the July issue of Drug a...s what the National Institute for Health and Clini...b (Macugen) are licensed in the UK for the treatme...
...ike Biotechnology Co., Ltd. announced that a team ...ital in Shenyang completed a study to assess clin...ntation of peripheral blood stem cells for patient...pinal cord injury and MS which are often covered b...
...ickens are coming home to roost? Those involved in...iable to infection because of some slip or other....rs for Disease Control and Prevention (CDC) has or...orts of lab workers infected with the category B b...
Other Medicine News:Health News:Jacqueline Kennedy Onnasis Phobia Over Daughters Weight Gain Revealed 2Health News:Acute Mountain Sickness may Lead to Pulmonary or Cerebral Edema 2Health News:Bird Flu in Asia Still High Risk Says WHO Official 2Health News:Draft National Policy on Sight-saving Drugs unacceptable 2Health News:Adult Stem Cells Show Promise for Peripheral Vascular Disease 2Health News:Bio-defense Lab Ordered Shut Down as Researchers Get Infected 2Health News:Bio-defense Lab Ordered Shut Down as Researchers Get Infected 3Health News:Bio-defense Lab Ordered Shut Down as Researchers Get Infected 4
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: